Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rothenberg

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Diabetes Care|May 4, 2017
Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar UlcersRobert G Frykberg, Ian L Gordon, Alexander M Reyzelman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
A phase I trial of human corticotropin-releasing factor (hCRF) in patients with peritumoral brain edemaM A Villalona-Calero, J Eckardt, H Burris, et al.
Leukemia|September 13, 2017
Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemiaK Reiter, H Polzer, C Krupka, et al.
Critical Care Medicine|January 22, 2002
Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care MedicineR D Truog, A F Cist, S E Brackett, et al.
Optics Letters|August 15, 2018
Differential phase-shift-keying demodulation by coherent perfect absorption in silicon photonicsAsif Ahmed, Hao Yang, Jacob M Rothenberg, et al.
Leukemia|December 19, 2017
Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemiaM Rothenberg-Thurley, S Amler, D Goerlich, et al.
Leukemia|October 18, 2014
Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemiaN Sandhöfer, K H Metzeler, M Rothenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodiumS G Eckhardt, H A Burris, J R Eckardt, et al.
Allergy|March 6, 2023
Detection of gut and mucosal peptides through TOMAHAQ in healthy individualsE S Parsons, F Liu, A Kaushik, et al.
Leukemia|December 22, 2015
The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia modelsS Dutta, A Krause, S Vosberg, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Diabetes Care|May 4, 2017
Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar UlcersRobert G Frykberg, Ian L Gordon, Alexander M Reyzelman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
A phase I trial of human corticotropin-releasing factor (hCRF) in patients with peritumoral brain edemaM A Villalona-Calero, J Eckardt, H Burris, et al.
Leukemia|September 13, 2017
Tyrosine kinase inhibition increases the cell surface localization of FLT3-ITD and enhances FLT3-directed immunotherapy of acute myeloid leukemiaK Reiter, H Polzer, C Krupka, et al.
Critical Care Medicine|January 22, 2002
Recommendations for end-of-life care in the intensive care unit: The Ethics Committee of the Society of Critical Care MedicineR D Truog, A F Cist, S E Brackett, et al.
Optics Letters|August 15, 2018
Differential phase-shift-keying demodulation by coherent perfect absorption in silicon photonicsAsif Ahmed, Hao Yang, Jacob M Rothenberg, et al.
Leukemia|December 19, 2017
Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemiaM Rothenberg-Thurley, S Amler, D Goerlich, et al.
Leukemia|October 18, 2014
Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemiaN Sandhöfer, K H Metzeler, M Rothenberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodiumS G Eckhardt, H A Burris, J R Eckardt, et al.
Allergy|March 6, 2023
Detection of gut and mucosal peptides through TOMAHAQ in healthy individualsE S Parsons, F Liu, A Kaushik, et al.
Leukemia|December 22, 2015
The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia modelsS Dutta, A Krause, S Vosberg, et al.
Pageof 15